243 related articles for article (PubMed ID: 24449972)
1. [Tegafur/gimeracil/oteracil (Teysuno), by oral administration].
Duh D; Warnez M
J Pharm Belg; 2013 Dec; (4):35-6. PubMed ID: 24449972
[No Abstract] [Full Text] [Related]
2. Just when you thought the fluorouracil debate was over: S-1 and gastric cancer.
Ilson D
J Clin Oncol; 2005 Oct; 23(28):6826-8. PubMed ID: 16145059
[No Abstract] [Full Text] [Related]
3. Tegafur + gimeracil + oteracil. Just another fluorouracil precursor.
Prescrire Int; 2013 May; 22(138):122. PubMed ID: 23819172
[TBL] [Abstract][Full Text] [Related]
4. [Two elderly patients with advanced gastric cancer responding to chronomodulation chemotherapy with tegafur + cisplatin + isovorin followed by oral administration of S-1].
Kobayashi A; Yamaguchi M
Gan To Kagaku Ryoho; 2001 Jul; 28(7):1003-7. PubMed ID: 11478129
[TBL] [Abstract][Full Text] [Related]
5. Feasibility study of adjuvant chemotherapy with S-1 (TS-1; tegafur, gimeracil, oteracil potassium) for gastric cancer.
Kinoshita T; Nashimoto A; Yamamura Y; Okamura T; Sasako M; Sakamoto J; Kojima H; Hiratsuka M; Arai K; Sairenji M; Fukushima N; Kimura H; Nakajima T
Gastric Cancer; 2004; 7(2):104-9. PubMed ID: 15224197
[TBL] [Abstract][Full Text] [Related]
6. [Gastric cancer with multiple liver metastases, which responded significantly to oral administration of TS-1 following intravenous FMP therapy under hospitalization].
Tasaka K; Okada Y; Tomofuji Y; Chinzei T
Gan To Kagaku Ryoho; 2002 Sep; 29(9):1631-5. PubMed ID: 12355951
[TBL] [Abstract][Full Text] [Related]
7. [Postoperative chemotherapy with a novel oral anticancer drug composed of tegafur, gimeracil and oteracil potassium to curability C scirrhus type gastric cancer].
Iwatani Y; Shimada Y; Ohshima T; Kusunoki N; Yamazaki T; Miyazaki N
Gan To Kagaku Ryoho; 2001 Aug; 28(8):1129-32. PubMed ID: 11525030
[TBL] [Abstract][Full Text] [Related]
8. The first case of phenytoin intoxication associated with the concomitant use of phenytoin and TS-1, a combination preparation of tegafur, gimeracil, and oteracil potassium.
Tsuda A; Fujiyama J; Miki A; Hori S; Ohtani H; Sawada Y
Cancer Chemother Pharmacol; 2008 Aug; 62(3):427-32. PubMed ID: 18026730
[TBL] [Abstract][Full Text] [Related]
9. The Clinical Evaluation of Tegafur Gimeracil Oteracil Combined with THP and DDP for Second-Line Treatment of Advanced Cardiac Carcinoma.
Wang HF; Lv JQ
Cell Biochem Biophys; 2015 Jul; 72(3):695-9. PubMed ID: 25618173
[TBL] [Abstract][Full Text] [Related]
10. Oral fluoropyrimidines in colorectal cancer.
Van Cutsem E; Peeters M
Semin Oncol; 2000 Oct; 27(5 Suppl 10):91-5. PubMed ID: 11049039
[No Abstract] [Full Text] [Related]
11. [Concentration of FT and CDHP and 5-FU in the ascites fluid of patient with peritoneal carcinomatosis after new anti-cancer drug TS-1 oral administration].
Iizuka R; Takahashi S; Kakihara N; Matsumura H; Takenaka A
Gan To Kagaku Ryoho; 2002 Jul; 29(7):1251-3. PubMed ID: 12146009
[No Abstract] [Full Text] [Related]
12. Complete response of Sister Mary Joseph Nodule from gastric adenocarcinoma treated with combination chemotherapy of low-dose S-1 and cisplatin.
Michiwa Y; Kamata T; Hayashi H; Hayashi Y; Minatoya G; Onishi I; Takeda T; Kanno M; Ueda Y
J Exp Clin Cancer Res; 2002 Dec; 21(4):609-11. PubMed ID: 12636109
[TBL] [Abstract][Full Text] [Related]
13. Esophageal cancer with colonic metastasis successfully treated by chemoradiotherapy followed by chemotherapy with S-1 and cisplatin.
Iwase H; Indo T; Shimada M; Tsuzuki T; Nakarai K; Kaida S; Doi R; Okeya M; Kato E
Int J Clin Oncol; 2004 Oct; 9(5):398-402. PubMed ID: 15549592
[TBL] [Abstract][Full Text] [Related]
14. Oral treatment for gastric cancer: new choices, better choices?
Cascinu S
Lancet Oncol; 2008 Mar; 9(3):188-9. PubMed ID: 18308239
[No Abstract] [Full Text] [Related]
15. [TS-1 therapy for advanced gastric cancer].
Kurihara M; Koizumi W; Hasegawa K; Sakata Y; Ohtsu A; Taguchi T
Nihon Rinsho; 2001 Apr; 59 Suppl 4():393-7. PubMed ID: 11424413
[No Abstract] [Full Text] [Related]
16. [Case report of a patient with advanced and disseminated gastric carcinoma treated by s-1].
Katolická J; Rotnáglová S; Vaníček J
Klin Onkol; 2014; 27(3):207-9. PubMed ID: 24918280
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of the efficacy of TS-1 for peritoneal dissemination of gastric cancer using a newly-developed animal model].
Mori T; Fujiwara Y; Takiguchi S; Yasuda T; Tamura S; Yano M; Monden M
Nihon Geka Gakkai Zasshi; 2002 May; 103(5):448. PubMed ID: 12048883
[No Abstract] [Full Text] [Related]
18. [A case report of tongue squamous cell carcinoma showing a complete response to TS-1].
Ikeda H; Takebe Y; Irie A; Mizoguchi Y; Yamada K; Shibahara K; Inokuchi T
Gan To Kagaku Ryoho; 2003 May; 30(5):677-9. PubMed ID: 12795100
[TBL] [Abstract][Full Text] [Related]
19. [The future of loco-regional treatment for advanced gastric cancer].
Nagahama T; Ando M; Ganno H; Ami K; Fukuda A; Maruyama M
Gan To Kagaku Ryoho; 2008 Nov; 35(12):2012-4. PubMed ID: 19106507
[TBL] [Abstract][Full Text] [Related]
20. High response rates in patients with pancreatic cancer using the novel oral fluoropyrimidine S-1.
Hayashi K; Imaizumi T; Uchida K; Kuramochi H; Takasaki K
Oncol Rep; 2002; 9(6):1355-61. PubMed ID: 12375048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
